Guidance in the Red / Amber List serves ONLY to define where clinical and prescribing responsibility for the listed medicines should lie in terms of governance and safety.
- Inclusion in this list does NOT imply the medicine has been accepted for use via Managed Entry, does NOT imply endorsement of use, and does NOT take account of the cost implications of use of a particular medicine.
- Prescribers should use this list in conjunction with guidance on the Managed entry process for medicines, and the NI formulary which includes information on current cost effective choices.
- For information relating to the Local Enhanced Service (NILES) relating to Additional Monitoring of Amber Drugs click here
- As far as possible, new specialist medicines are added to the list at the point when they are granted a UK product licence. In some instances this may be prior to the medicine being launched.
The table below lists specialist medicines. Users should search by generic name where possible. Brand names listed are not exhaustive.
Click to Show NEW entries only or limit alphabetically (by generic name): A-B C-D E-J K-M N-R S-Z
Approved Name | Example Trade Names | Context | Status | Guidance | New Entry |
---|---|---|---|---|---|
5 Aminolaevulinic acid gel | Ameluz | Red | |||
Abacavir | Red | ||||
Abacavir with dolutegravir and lamivudine | Triumeq | Red | |||
Abacavir with lamivudine | Kivexa | Red | |||
Abacavir with lamivudine and zidovudine | Trizivir | Red | |||
Abatacept | Orencia | Red | |||
Abemaciclib | Red | ||||
Abiraterone | Zytiga | Red | |||
Abrocitinib | Cibinqo | Red | |||
Acalabrutinib | Calquence | Red | |||
Acitretin | Neotigason | Red | |||
Adalimumab | Humira | Red | |||
Adefovir | Hepsera | Red | |||
Afamelanotide | Scenesse | Red | |||
Afatinib | Tomtovok | Red | |||
Aflibercept | Eylea, Zaltrap. | Red | |||
Agomelatine | Valdoxan | Amber status only applies to cover the required monitoring during the first 24 weeks of treatment after which time the arrangement can be stepped down | Amber | Shared Care Guideline in development | |
Alectinib | Alecensa | Red | |||
Alemtuzumab | MabCampath, Lemtrada | Red | |||
Alipogene tiparvovec | Glybera | Red | |||
Alirocumab | Praluent | Amber | GP Information Sheet | ||
Alitretinoin | Toctino | Red | |||
Alpelisib | Red | ||||
Alprostadil | Caverject, MUSE, Viridal Duo, Vitaros | Erectile dysfunction - severe distress category only | Red | ||
Ambrisentan | Volibris | Red | |||
Amifampridine | Firdapse | Red | |||
Amikacin Inhaled | Arikayce | Red | |||
Amiodarone | Cordarone X | Amber | Amiodarone Shared Care Guideline | ||
Amivantamab | Rybrevant | Red | |||
Anagrelide | Xagrid | Red | |||
Anakinra | Kineret | Red | |||
Anti-lymphocyte immunoglobulin (horse) | Atgam | Red | |||
Antibiotics (IV/parenteral) | Except when for emergency use in doctors’ bags such as Benzylpenicillin or Cefotaxime Or IV antibiotics prescribed as part of a GP Enhanced Service that is supported by Trust Outpatient Parenteral Antibiotic Therapy (OPAT) services or similar services. | Red | |||
Antiretrovirals | Red | ||||
Apalutamide | Erleada | Red | |||
Apomorphine | APO-go | Amber | Apomorphine Shared Care Guideline | ||
Apremilast | Otezla | Amber | No Shared Care Guideline Required (Click for info) | ||
Arachis hypogaea | Palforzia | Red | |||
Argatroban | Exembol | Red | |||
Arsenic | Trisenox | Red | |||
Asciminib | Scemblix | Red | |||
Asfotase alfa | Strensiq | Red | |||
Ataluren | Translarna | Red | |||
Atazanavir | Red | ||||
Atazanavir (with cobicistat) | Evotaz | Red | |||
Atezolizumab | Tecentriq | Red | |||
Atomoxetine | Strattera | Amber | Atomoxetine Shared Care Guideline | ||
Avacopan | Tavneos | Red | |||
Avalglucosidase alfa | Nexviadyme | Red | |||
Avanafil | Spedra | Erectile dysfunction - severe distress category only | Red | ||
Avapritinib | Ayvakit | Red | |||
Avatrombopag | Doptelet | Red | |||
Avelumab | Bavencio | Red | |||
Axicabtagene ciloleucel | Red | ||||
Axitinib | Inlyta | Red | |||
Azacitadine | Vidaza | Red | |||
Azathioprine | Imuran | Immunosuppressant post transplantation | Amber | Azathioprine Post Transplant Shared Care Guideline | |
Azathioprine | Imuran | Non transplant indications | Amber | Azathioprine (Other Non-Transplant Indications) Shared Care Guideline | |
Aztreonam (Inhaled) | Cayston | Inhaled for chronic pulmonary infections | Red | ||
Baricitinib | Olumiant | Red | |||
Bedaquiline | Sirturo | Red | |||
Belantamab mafodotin | Blenrep | Red | |||
Belimumab | Benlysta | Red | |||
Belzutifan | Welireg | Red | |||
Benralizumab | Red | ||||
Berotralstat | Orladeyo | Red | |||
Betaine | Cystadane | Amber | GP Information sheet | ||
Bevacizumab | Avastin | Red | |||
Bexarotene | Targretin | Red | |||
Bezlotoxumab | Zinplava | Red | |||
Bicalutamide | Casodex | Amber | No Shared Care Guideline Required (Click for info) | ||
Bictegravir + emtricitabine + tenofovir alafenamide | Biktarvy | Red | |||
Bimekizumab | Bimzelx | Red | |||
Binimetinib | Red | ||||
Blinatumomab | Blincyto | Red | |||
Boceprevir | Victrelis | Red | |||
Bortezomib | Velcade | Red | |||
Bosentan | Tracleer | Red | |||
Bosutinib | Bosulif | Red | |||
Botulinum toxin type A and B | various brands | For all uses except cosmetic | Red | ||
Brentuximab | Adcetris | Red | |||
Brigatinib | Alunbrig | Red | |||
Brodalumab | Kyntheum | Red | |||
Bromelain | Nexobrid | Red | |||
Bulevirtide | Hepcludex | Red | NEW | ||
Burosumab | Crysvita | Red | |||
Buserelin | Suprecur, Suprefact | When used for treatment of infertility | Red | ||
Busulfan | Myleran | Red | |||
C1 esterase inhibitor | Cinryze, Berinert | Red | |||
Cabergoline | Cabaser | Amber | Cabergoline Neurology Shared Care Guideline | ||
Cabergoline | Dostinex | Amber | Cabergoline Endocrinology Shared Care Guideline | ||
Cabotegravir | Red | ||||
Cabozantinib | Cometriq | Red | |||
Canakinumab | Ilaris | Red | |||
Cannabidiol (as Epidyolex) | Lennox Gastaut syndrome or Dravet syndrome | Red | |||
Cannabis buccal mucosal spray | Sativex | Red | |||
CAPD | Continuous Ambulatory Peritoneal Dialysis solutions | Red | |||
Capecitabine | Xeloda | Red | |||
Caplacizumab | Red | ||||
Capsaicin patch | Qutenza | Red | |||
Carfilzomib | Kyprolis | Red | |||
Cemiplimab | Libtayo | Red | |||
Ceritinib | Zykadia | Red | |||
Certolizumab pegol | Cimzia | Red | |||
Cetrorelix | Cetrotide | Red | |||
Chenodeoxycholic acid | Xenbilox | Red | |||
Chlorambucil | Leukeran | Red | |||
Chloroquine | Nivaquine | Non-malaria indications | Amber | No Shared Care Guideline Required (Click for info) | |
Choriogonadotropin | Ovitrelle | Infertility | Red | ||
Chorionic gonadotrophin | Choragon, Pregnyl | Infertility | Red | ||
Ciclosporin | Neoral | Immunosuppressant post transplantation | Amber | Ciclosporin Post Transplant Shared Care Guideline | |
Ciclosporin | Neoral | Non transplant indications | Amber | Ciclosporin (Non-Transplant Indications) Shared Care Guideline | |
Cinacalcet | Mimpara | Amber | Cinacalcet Shared Care Guideline | ||
Cladribine | Mavenclad | Multiple sclerosis | Red | ||
Clomifene | Clomid | Amber | Clomifene Shared Care Guideline | ||
Clonidine | ADHD and other behavioural and neurodevelopmental disorders | Amber | No Shared Care Guideline Required (Click for Info) | ||
Clozapine | Clozaril | Red | |||
Cobicistat | Tybost | Red | |||
Cobimetinib | Cotellic | Red | |||
Colistimethate sodium (Inhaled) | Colomycin | Amber | Colistimethate Shared Care Guideline | ||
Collagenase clostridium histolyticum | Xiapex | Red | |||
Conestat alfa | Ruconest | Red | |||
Crizanlizumab | Adakveo | Red | |||
Crizotinib | Xalkori | Red | |||
Cyclophosphamide | When used as a systemic anti-cancer therapy | Red | |||
Cyclophosphamide (oral) | Non-cancer indications | Amber | Cyclophosphamide Shared Care Guideline | ||
Cytarabine and daunorubicin liposomal | Red | ||||
Cytotoxics IV | various examples | Red | |||
Dabrafenib | Tafinlar | Red | |||
Daclatasvir | Daklinza | Red | |||
Daclizumab | Zinbryta | Red | |||
Dacomitinib | Vizimpro | Red | |||
Dalteparin sodium | Fragmin | Amber | |||
Dapsone | Dermatology / Immunology | Amber | Dapsone Shared Care Guideline | ||
Daratumumab | Darzalex | Red | |||
Darbepoetin | Aranesp | Amber | Local Arrangements For Shared Care May Apply (click for info) | ||
Darolutamide | Nubeqa | Red | |||
Darunavir | Red | ||||
Darunavir + cobicistat | Rezolsta | Red | |||
Darunavir + cobicistat + emtricitabine + tenofovir alafenamide | Symtuza | Red | |||
Dasabuvir | Exviera | Red | |||
Dasatinib | Sprycel | Red | |||
Deferasirox | Exjade | Red | |||
Deferiprone | Ferriprox | Red | |||
Defibrotide | Defitelio | Red | |||
Delamanid | Deltyba | Red | |||
Demeclocycline | SIADH | Amber | Demeclocycline Shared Care Guideline | ||
Denosumab | Prolia | Osteoporosis | Amber | Denosumab (Prolia) Shared Care Guideline | |
Denosumab | Xgeva | Bone metastases from solid tumours; giant cell tumour of bone | Red | ||
Desferrioxamine | Desferal | Chronic iron overload | Amber | No Shared care Guideline Required (Click for info) | |
Desferrioxamine | Desferal | Treatment of iron poisoning | Red | ||
Deucravacitinib | Sotyktu | Red | |||
Dexamethasone Implant | Ozurdex | Intravitreal injection route | Red | ||
Dexamfetamine | Dexedrine | Attention deficit hyperactivity disorder in adults and children 6 years and over, within NICE recommended doses, and for use in narcolepsy. | Amber | Dexamfetamine Shared care Guideline | |
Dexamfetamine | Dexedrine | Attention deficit hyperactivity disorder in children under 6 years, or doses over NICE recommended doses | Red | ||
Dimethyl fumarate | Skilarence | Psoriasis | Amber | Dimethyl fumarate (Skilarence) shared care guideline | |
Dimethyl Fumarate | Tecfidera | Multiple sclerosis | Red | ||
Dinutuximab | Unituxin | Red | |||
Diroximel fumarate | Vumerity | Red | |||
Dolutegravir | Tivicay | Red | |||
Dolutegravir + abacavir + lamivudine | Triumeq | Red | |||
Dolutegravir + rilpivirine | Juluca | Red | |||
Doravirine | Pifeltro | Red | |||
Doravirine + lamivudine + tenofovir disoproxil fumarate | Delstrigo | Red | |||
Dornase alfa | Pulmozyme | Amber | No Shared Care guideline required (Click for info) | ||
Dostarlimab | Jemperli | Red | |||
Dronedarone | Multaq | Amber | Dronedarone Shared Care Guideline | ||
Dupilumab | Dupixent | Red | |||
Durvalumab | Red | ||||
Duvelisib | Copiktra | Red | |||
Eculizumab | Soliris | Red | |||
Efavirenz | Red | ||||
Efavirenz with emtricitabine and tenofovir disoproxil | Red | ||||
Efgartigimod | Vyvgart | Red | NEW | ||
Efmoroctocog alfa | Elocta | Red | |||
Eliglustat | Cerdelga | Red | |||
Elosulfase alfa | Vimizim | Red | |||
Elotuzumab | Empliciti | Red | |||
Elranatamab | Elrexfio | Red | NEW | ||
Eltrombopag | Revolade | Red | |||
Elvitegravir | Vitekta | Red | |||
Elvitegravir with cobicistat, emtricitabine and tenofovir alafenamide | Stribild | Red | |||
Elvitegravir with cobicistat, emtricitabine and tenofovir disoproxil | Genvoya | Red | |||
Emicizumab | Red | ||||
Emtricitabine | Emtriva | Red | |||
Emtricitabine + tenofovir alafenamide | Descovy | Red | |||
Emtricitabine with rilpivirine and tenofovir alafenamide | Odefsey | Red | |||
Emtricitabine with rilpivirine and tenofovir disoproxil | Eviplera | Red | |||
Emtricitabine with tenofovir disoproxil | Red | ||||
Emtricitabine, tenofovir, elvitegravir, cobicistat | Stribild | Red | |||
Encorafenib | Red | ||||
Enfortumab vedotin | Padcev | Red | |||
Enfuvirtide | Fuzeon | Red | |||
Enoxaparin | Clexane | Amber | Enoxaparin Shared Care Guideline | ||
Entecavir | Baraclude | Red | |||
Entrectinib | Red | ||||
Enzalutamide | Xtandi | Red | |||
Epcoritamab | Tepkinly | Red | NEW | ||
Epoetin | Eprex, NeoRecormon | Amber | Local Arrangements For Shared Care May Apply | ||
Epoprostenol | Flolan | Red | |||
Eptinezumab | Vyepti | Red | |||
Erenumab | Aimovig | Amber | GP Information Sheet | ||
Eribulin | Halaven | Red | |||
Erlotinib | Tarceva | Red | |||
Esketamine | Spravato | Red | |||
Estramustine | Estracyt | Red | |||
Etanercept | Enbrel | Red | |||
Etelcalcetide | Parsabiv | Red | |||
Etoposide | Vepesid | Red | |||
Etravirine | Intelence | Red | |||
Everolimus | Certican | Post-transplant immunosuppressant | Amber | No Shared Care Guideline Required (Click for info) | |
Everolimus | Afinitor, Votubia | When used as a systemic anti-cancer therapy or for manifestations of tuberous sclerosis complex | Red | ||
Evinacumab | Evkeeza | Red | NEW | ||
Evolocumab | Repatha | Amber | GP Information sheet | ||
Fampridine | Fampyra | Red | |||
Faricimab | Vabysmo | Red | |||
Fenfluramine | Fintepla | Red | |||
Filgotinib | Jyseleca | Red | |||
Filgrastim | Neupogen, Accofil, Zarzio | Red | |||
Fingolimod | Gilenya | Red | |||
Fludarabine | Fludara | Red | |||
Fluocinolone Intravitreal Implant | Iluvien | Red | |||
Flutamide | Drogenil | Amber | No Shared Care Guideline Required (Click for info) | ||
Follitropin alfa, beta & delta | Gonal-F, Puregon, Ovaleap, Bemfola, Pergoveris, Rekovelle | Infertility | Red | ||
Fondaparinux | Arixtra | Amber | |||
Fosamprenavir | Telzir | Red | |||
Fostamatinib | Tavlesse | Red | |||
Fremanezumab | Ajovy | Amber | GP Information Sheet | ||
Galcanezumab | Emgality | Amber | GP information sheet | ||
Galsulfase | Naglazyme | Red | |||
Ganciclovir IV | Cymevene | Red | |||
Ganirelix | Orgalutran | Infertility | Red | ||
Gefitinib | Iressa | Red | |||
Gemtuzumab | Mylotarg | Red | |||
Gilteritinib | Xospata | Red | |||
Givosiran | Givlaari | Red | |||
Glasdegib | Red | ||||
Glatiramer acetate | Copaxone | Red | |||
Glecaprevir + pibrentasvir | Maviret | Red | |||
Glycerol phenylbutyrate | Ravicti | Amber | GP Information Sheet | ||
Golimumab | Simponi | Red | |||
Gonadorelin analogues | Suprecur, Suprefact, Prostap, Zoladex, Synarel, Decapeptyl | When used for treatment of infertility. | Red | ||
Goserelin | Zoladex | When used for treatment of infertility | Red | ||
Grass pollen extract | Grazax | Amber | GP Information Sheet | ||
Grazoprevir + elbasvir | Zepatier | Red | |||
Guanfacine | Intuniv | Amber | Guanfacine Shared Care Guideline | ||
Guselkumab | Tremfya | Red | |||
House dust mite immunotherapy | Acarizax | Red | |||
Human alpha1-proteinase inhibitor | Respreeza | Red | |||
Human FVIII and Human VWF | Voncento | Red | |||
Human menopausal gonadotrophins | Menogon, Menopur | Infertility | Red | ||
Human von Willebrand factor (VWF) | Willfact | Red | |||
Hydroxycarbamide | Hydrea | Myeloproliferative disorders and other non-cancer indications. | Amber | Hydroxycarbamide Shared Care Guideline | |
Hydroxycarbamide | Hydrea | When used as a systemic anti cancer therapy | Red | ||
Hydroxychloroquine | Plaquenil | Amber | Hydroxychloroquine Shared Care Guideline | ||
Ibandronate IV injection | Bonviva | Red | |||
Ibrutinib | Imbruvica | Red | |||
Icatibant | Firazyr | Red | |||
Idarubicin | Zavedos | Red | |||
Idebenone | Raxone | Leber's Hereditary Optic Neuropathy | Red | ||
Idelalisib | Zydelig | Red | |||
Idursulfase | Elaprase | Red | |||
Iloprost | Ilomedin, Ventavis | Red | |||
Imatinib | Glivec | Red | |||
Imiglucerase | Cerezyme | Red | |||
Immunoglobulin | Cuvitru, Gammabulin, Gammagard, Kabiglobulin, Flebogamma, Sandoglobulin, Subcuvia, Vigam | Specialist indications | Red | ||
Inclisiran | Leqvio | Red | |||
Infliximab | Remicade | Red | |||
Inotersen | Tegsedi | Red | |||
Inotuzumab ozogamicin | Besponsa | Red | |||
Interferon alfa | Intron-A, Roferon-A | Red | |||
Interferon beta | Avonex, Rebif, Betaferon | Red | |||
Interferon gamma | Immukin | Red | |||
Ipilimumab | Yervoy | Red | |||
Irinotecan | Red | ||||
Iron (Parenteral) | Monofer, Cosmofer, Venofer, Ferinject, Rienso | Red | |||
Isatuximab | Sarclisa | Red | |||
Isavuconazole | Cresemba | Red | |||
Isocarboxazid | Isocarboxazid | Amber | No Shared Care Guideline Required (Click for info) | ||
Isotretinoin | Roaccutane | Red | |||
Itulazax | Red | ||||
Ivabradine | Procoralan | Chronic heart failure NYHA class II to IV | Amber | No Shared Care Guideline Required (Click for info) | |
Ivacaftor | Kalydeco | Red | |||
Ivacaftor + Tezacaftor + Elexacaftor | Kaftrio | Red | |||
Ivosidenib | Tibsovo | Red | |||
Ixazomib | Ninlaro | Red | |||
Ixekizumab | Taltz | Red | |||
Ketamine | Ketalar, Ketamine oral solution | Palliative Care (outside licence) | Amber | Ketamine Shared Care Guideline | |
Ketamine | Ketalar, Ketamine oral solution | Neuropathic pain | Red | ||
Ketanserin | Sufrexal | Red | |||
Ketoconazole HRA | Ketoconazole HRA | HRA formulation (for Cushing's syndrome) only | Red | ||
L-Tryptophan | Optimax | Amber | No Shared Care Guideline Required (Click for info) | ||
Lamivudine | Zeffix | Red | |||
Lamivudine with dolutegravir | Dovato | Red | |||
Lamivudine with tenofovir disoproxil | Red | ||||
Lamivudine with tenofovir disoproxil and doravirine | Delstrigo | Red | |||
Lanadelumab | Takhzyro | Red | |||
Lanreotide | Somatuline | Neuroendocrine tumours and acromegaly. Within licence | Amber | Lanreotide Shared Care Guideline | |
Lanreotide | Somatuline | Outside licence | Red | ||
Lapatinib | Tyverb | Red | |||
Larotrectinib | Vitrakvi | Red | |||
Leflunomide | Arava | Amber | Leflunomide Shared Care Guideline | ||
Lenacapavir | Sunlenca | Red | |||
Lenalidomide | Revlimid | Red | |||
Lenograstim | Granocyte | Red | |||
Lenvatinib | Lenvima | Red | |||
Letermovir | Prevymis | Red | |||
Leuprorelin | Prostap, Lutrate | When used for treatment of infertility | Red | ||
Levofloxacin nebuliser solution | Quinsair | Red | |||
Linezolid | Zyvox | Red | |||
Liothyronine | Management of thyroid disorders | Amber | Liothyronine Shared Care Guideline | ||
Lipegfilgrastim | Lonquex | Red | |||
Lisdexamfetamine | Elvanse | Amber | Lisdexamfetamine Shared Care Guideline | ||
Lithium | Camcolit, Liskonum, Priadel | Amber | Lithium Shared Care Guideline | ||
Lofexidine | BritLofex | Red | |||
Lomitapide | Lojuxta | Red | |||
Lomustine | Red | ||||
Loncastuximab tesirine | Zynlonta | Red | |||
Lopinavir + ritonavir | Kaletra | Red | |||
Lorlatinib | Lorviqua | Red | |||
Lumacaftor (with ivacaftor) | Orkambi | Red | |||
Lumasiran | Oxlumo | Red | |||
Luspatercept | Reblozyl | Red | |||
Lusutrombopag | Mulpleo | Red | |||
Lutetium (177Lu) vipivotide tetraxetan | Pluvicto | Red | |||
Lutetium(177Lu) oxodotreotide | Lutathera | Red | |||
Lutropin | Luveris, Pergoveris | Red | |||
Macitentan | Opsumit | Red | |||
Maraviroc | Celsentri | Red | |||
Maribavir | Livtencity | Red | |||
Mecasermin | Increlex | Red | |||
Melatonin | Amber | Melatonin Shared Care Guideline | |||
Melphalan | Alkeran | Red | |||
Mepolizumab | Nucala | Red | |||
Mercaptamine (oral) | Cystagon, Procysbi | Amber | No Shared Care Guideline Required (Click for info) | ||
Mercaptamine eyedrops | Cystadrops | Amber | No Shared Care Guideline Required (Click for info) | ||
Mercaptopurine | For non-cancer indications | Amber | Mercaptopurine Shared Care Guideline | ||
Mercaptopurine | When used as a systemic anti-cancer therapy | Red | |||
Methotrexate | oral | For non-cancer indications | Amber | Methotrexate oral Shared Care Guideline | |
Methotrexate | Subcutaneous (Metoject) | For non-cancer indications | Amber | Methotrexate subcutaneous Shared Care Guideline | |
Methotrexate | oral | When used as a systemic anti-cancer therapy | Red | ||
Methotrexate | parenteral (other than subcutaneous) | All indications | Red | ||
Methyl aminolevulinate cream | Metvix | Red | |||
Methylphenidate | Ritalin, Equasym, Concerta XL, Delmosart | For attention deficit hyperactivity disorder in adults and children 6 years and over, within NICE recommended doses. | Amber | Methylphenidate Shared Care Guideline | |
Methylphenidate | Ritalin, Equasym, Concerta XL, Delmosart | For attention deficit hyperactivity disorder in children under 6 years, or doses over NICE recommended doses. | Red | ||
Metreleptin | Myalepta | Red | |||
Metyrapone | Amber | NEW | |||
Mexiletine | Non-proprietary | Cardiology | Amber | Mexiletine Shared Care Guideline | |
Midostaurin | Red | ||||
Migalastat | Galfold | Red | |||
Miglustat | Zavesca | Red | |||
Mirikizumab | Omvoh | Red | NEW | ||
Mitotane | Lysodren | Red | |||
Mobocertinib | Exkivity | Red | |||
Moclobemide | Manerix | Amber | No Shared Care Guideline Required (Click for info) | ||
Modafinil | Provigil | Amber | No Shared Care Guideline Required (Click for info) | ||
Mogamulizumab | Poteligeo | Red | |||
Monacog alfa | BeneFix | Red | |||
Moroctocgog alfa | ReFacto | Red | |||
Mosunetuzumab | Lunsumio | Red | |||
Mycophenolate mofetil | CellCept | Non transplant indications | Amber | Mycophenolate mofetil (other non-transplant indications) shared care guideline | |
Mycophenolate mofetil | CellCept | Immunosuppressant post transplantation | Amber | Mycophenolate mofetil Post Transplant Shared Care Guideline | |
Nabilone | Red | ||||
Nafarelin | Synarel | When used for treatment of infertility | Red | ||
Naltrexone | Nalorex | Amber | No Shared Care Guideline Required (Click for info) | ||
NaMuscla® | Myotonia | Red | |||
Natalizumab | Tysabri | Red | |||
Necitumumab | Portrazza | Red | |||
Neratinib | Nerlynx | Red | |||
Nevirapine | Viramune | Red | |||
Nilotinib | Tasigna | Red | |||
Nintedanib | Vargatef , Ofev | Red | |||
Niraparib | Zejula | Red | |||
Niraparib / Abiraterone | Akeega | Red | NEW | ||
Nivolumab | Opdivo | Red | |||
Nivolumab / Relatlimab | Opdualag | Red | NEW | ||
Nusinersen | Spinraza | Red | |||
Obinutuzumab | Gazyvaro | Red | |||
Ocrelizumab | Ocrevus | Red | |||
Ocriplasmin | Jetrea | Red | |||
Octocog alfa | Advate | Red | |||
Octreotide | Sandostatin | Neuroendocrine tumours and acromegaly. Within licence. | Amber | Octreotide Endocrinology Shared Care Guideline | |
Octreotide | Sandostatin | Palliative Care | Amber | Octreotide Palliative Care Shared Care Guideline | |
Octreotide | Sandostatin | Outside licence (except Palliative Care) | Red | ||
Odevixibat | Bylvay | Red | |||
Ofatumumab | Kesimpta | Red | |||
Olanzapine Long Acting Injection | Zypadhera | Red | |||
Olaparib | Lynparza | Red | |||
Olaratumab | Red | ||||
Olipudase alfa | Xenpozyme | Red | NEW | ||
Omalizumab | Xolair | Red | |||
Osimertinib | Tagrisso | Red | |||
Ozanimod | Zeposia | Red | |||
Paclitaxel | Red | ||||
Padeliporfin | Tookad | Red | |||
Palbociclib | Ibrance | Red | |||
Palivizumab | Synagis | Red | |||
Pamidronate Disodium | Aredia | Red | |||
Panobinostat | Farydak | Red | |||
Parathyroid hormone subcutaneous injection | Preotact | Red | |||
Paritaprevir + ritonavir + ombitasvir | Viekirax | Red | |||
Paritaprevir + ritonavir + ombitasvir +/- dasabuvir | Red | ||||
Pasireotide | Signifor | Red | |||
Patisiran | Onpattro | Red | |||
Pazopanib | Votrient | Red | |||
Pegaspargase | Oncaspar | Red | |||
Pegcetacoplan | Aspaveli | Red | |||
Pegfilgrastim | Neulasta | Red | |||
Peginterferon alfa | PegIntron, ViraferonPeg, Pegasys | Red | |||
Peginterferon beta-1a | Plegridy | Red | |||
Pegloticase | Krystexxa | Red | |||
Pegunigalsidase alfa | Elfabrio | Red | NEW | ||
Pegvaliase | Palynziq | Red | |||
Pegvisomant | Somavert | Red | |||
Pembrolizumab | Kytruda | Red | |||
Pemigatinib | Pemazyre | Red | |||
Penicillamine | Distamine | Amber | Penicillamine Shared Care Guideline | ||
Pentosan polysulfate sodium | Red | ||||
Pertuzumab | Perjeta | Red | |||
Phenelzine | Nardil | Amber | No Shared Care Guideline Required (Click for info) | ||
Phenylbutazone | Butacote | Red | |||
Pirfenidone | Esbriet | Red | |||
Pixantrone | Pixuvri | Red | |||
Plerixafor | Mozobil | Red | |||
Polatuzumab | Polivy | Red | |||
Pomalidomide | Imnovid | Red | |||
Ponatinib | Iclusig | Red | |||
Ponesimod | Ponvory | Red | |||
Posaconazole | Noxafil | Red | |||
Pralsetinib | Gavreto | Red | |||
Procarbazine | Red | ||||
Radium | Xofigo | Red | |||
Raltegravir | Isentress | Red | |||
Raltegravir + lamivudine | Dutrebis | Red | |||
Ramucirumab | Cyramza | Red | |||
Ranibizumab | Lucentis | Red | |||
Ravulizumab | Ultomiris | Red | |||
Regorafenib | Stivarga | Red | |||
Reslizumab | Cinqaero | Red | |||
Ribavirin | Rebetol, Virazole, Copegus | Red | |||
Ribociclib | Kisqali | Red | |||
Rilpivirine | Edurant | Red | |||
Riluzole | Rilutek | Amber | Riluzole Shared Care Guideline | ||
Riociguat | Adempas | Red | |||
Ripretinib | Quinlock | Red | |||
Risankizumab | Skyrizi | Red | |||
Risdiplam | Evrysdi | Red | |||
Ritonavir | Norvir | Red | |||
Rituximab | MabThera | Red | |||
Romiplostim injection | Nplate | Red | |||
Romosozumab | Red | ||||
Ropeginterferon alfa-2b | Besremi | ||||
Roxadustat | Evrenzo | Red | |||
Rucaparib | Rucaparib | Red | |||
Ruxolitinib | Jakavi | Red | |||
Sacituzumab govitecan | Trodelvy | Red | |||
Sapropterin | Kuvan | Red | |||
Saquinavir | Invirase | Red | |||
Sarilumab | Kevzara | Red | |||
Sebelipase alfa | Kanuma | Red | |||
Secukinumab | Cosentyx | Red | |||
Selexipag | Uptravi | Red | |||
Selinexor | Nexpovio | Red | |||
Selpercatinib | Retsevmo | Red | |||
Selumetinib | Koselugo | Red | |||
Setmelanotide | Imcivree | Red | |||
Sildenafil | Revatio | Pulmonary arterial hypertension | Amber | Sildenafil Shared Care Guideline | |
Sildenafil | Viagra | Erectile dysfunction - severe distress category only | Red | ||
Siltuximab | Sylvant | Red | |||
Simeprevir | Olysio | Red | |||
Siponimod | Mayzent | Red | |||
Sirolimus | Rapamune | Amber | Sirolimus Shared Care Guideline | ||
Sodium clodronate | Bonefos | IV only; hypercalcaemia of malignancy | Red | ||
Sodium oxybate | Xyrem | Red | |||
Sodium phenylbutyrate | Ammonaps | Amber | GP Information Sheet | ||
Sofosbuvir | Solvadi | Red | |||
Sofosbuvir + ledipasvir | Harvoni | Red | |||
Sofosbuvir + velpatasvir | Epclusa | Red | |||
Sofosbuvir + voxilaprevir + velpatasvir | Vosevi | Red | |||
Somapacitan | Sogroya | Amber | Shared Care Guideline In Development | ||
Somatrogon | Ngenla | Amber | Shared Care Guideline In Development | ||
Somatropin | Genotropin, Norditropin, Humatrope, Saizen, Zomacton | Amber | Somatropin Shared Care Guideline | ||
Sonidegib | Odomzo | Red | |||
Sorafenib | Nexavar | Red | |||
Sotorasib | Lumykras | Red | |||
Stiripentol | Diacomit | Amber | GP Information sheet | ||
Sulfasalazine | Salazopyrin | Amber | Sulfasalazine Shared Care Guideline | ||
Sunitinib | Sutent | Red | |||
Tacrolimus | Prograf | Immunosuppressant post transplantation | Amber | Tacrolimus Post Transplant Shared Care Guideline | |
Tacrolimus | Prograf | Non-transplant indications | Amber | Tacrolimus Non-Transplant Shared Care Guideline | |
Tadalafil | Adcirca | Pulmonary arterial hypertension | Amber | Tadalafil Shared Care Guideline | |
Tadalafil | Cialis | Erectile dysfunction - severe distress category only | Red | ||
Tafamidis | Vyndaqel | Red | |||
Tafasitamab | Minjuvi | Red | |||
Talazoparib | Talzenna | Red | |||
Talimogene laherparepvec | Imlygic | Red | |||
Tebentafusp | Kimmtrak | Red | |||
Teclistamab | Tecvayli | Red | |||
Tedizolid | Sivextro | Red | |||
Teduglutide | Revestive | Red | |||
Tegafur with gimeracil and oteracil | Teysuno | Red | |||
Tegafur with uracil | Uftoral | Red | |||
Teicoplanin | Targocid | Red | |||
Telaprevir | Incivo | Red | |||
Telbivudine | Sebivo | Red | |||
Telotristat | Xermelo | Red | |||
Temozolomide | Temodal | Red | |||
Tenofovir | Viread | Red | |||
Tenofovir, alafenamide, elvitegravir, cobicistat + emtricitabine | Genvoya | Red | |||
Tepotinib | Tepmetko | Red | |||
Teriflunomide | Aubagio | Red | |||
Teriparatide | Forsteo | Red | |||
Testosterone | Amber | Testosterone Shared Care Guideline | |||
Tezacaftor with Ivacaftor | Symkevi | Red | |||
Tezepelumab | Tezspire | Red | |||
Thalidomide | Pharmion | Red | |||
Thioridazine | Red | ||||
Tildrakizumab | Ilumetri | Red | |||
Tinzaparin Sodium | Innohep | Amber | No Shared Care Guideline Required (Click for info) | ||
Tioguanine | Lanvis | Red | |||
Tipiracil + trifluridine | Lonsurf | Red | |||
Tipranavir | Aptivus | Red | |||
Tivozanib | Fotivda | Red | |||
Tobramycin | Tobi, Nebcin | IV or nebulised | Red | ||
Tocilizumab | RoActemra | Red | |||
Tofacitinib | Xeljanz | Red | |||
Tolcapone | Tasmar | Amber | Tolcapone Shared Care Guideline | ||
Tolvaptan | Samsca, Jinarc | Red | |||
Topotecan | Hycamtin | Red | |||
Total Parenteral Nutrition (TPN Solutions) | Red | ||||
Tralokinumab | Adtralza | Red | |||
Trametinib | Mekinist | Red | |||
Tranylcypromine | Amber | No Shared Care Guideline Required (Click for info) | |||
Trastuzumab | Herceptin, including Herceptin SC | Red | |||
Trastuzumab deruxtecan | Enhertu | Red | |||
Trastuzumab emtansine | Kadcyla | Red | |||
Treosulfan | Red | ||||
Treprostinil | Red | ||||
Tretinoin | Vesanoid | Red | |||
Trientine | Amber | No Shared Care Guideline Required (Click for info) | |||
Triptorelin | Decapeptyl, Gonapeptyl, Salvacyl | When used for treatment of infertility | Red | ||
Tucatinib | Tukysa | Red | |||
Turoctocog alfa | NovoEight | Red | |||
Ulipristal (as Esmya) | Uterine fibroids | Amber | Shared Care Guideline in development | ||
Unlicensed Cannabis Based Products for Medicinal Use (CBPM) Licensed CBPMs are considered separately under their Brand Names. | > A cannabis-based medicine must meet the definition of the 2018 No 173 The Misuse of Drugs (Amendment No 2) Regulations (Northern Ireland). > If it is not a licensed medicine (UK) the CBPM should meet the definition of a special medicinal product and be for use in accordance with a prescription or direction of a specialist medical practitioner | Red | |||
Upadacitinib | Rinvoq | Red | |||
Ustekinumab | Stelara | Red | |||
Valganciclovir | Valcyte | Red | |||
Vandetanib | Caprelsa | Red | |||
Vardenafil | Levitra | Erectile dysfunction - severe distress category only | Red | ||
Vedolizumab | Entyvio | Red | |||
Velaglucerase alfa | VPRIV | Red | |||
Vemurafenib | Zelboraf | Red | |||
Venetoclax | Venclyxto | Red | |||
Venlafaxine | Efexor | Only considered specialist medicine (Amber category) at doses greater than 300mg daily | Amber | No Shared Care Guideline Required (Click for info) | |
Vestronidase | Mepsevii | Red | |||
Vinorelbine | Navelbine | Red | |||
Vismodegib | Erivedge | Red | |||
Volanesorsen | Waylivra | Red | |||
Vonicog alfa | Veyvondi | Red | |||
Voriconazole | Vfend | Red | |||
Vutrisiran | Amvuttra | Red | NEW | ||
Warfarin | Amber sub-group | Local Arrangements For Shared Care May Apply | |||
Zanubrutinib | Brukinsa | Red | |||
Zidovudine | Retrovir | Red | |||
Zidovudine with lamivudine | Combivir | Red | |||
Zoledronic acid | Aclasta, Zometa | Red |
You can also Download the Red Amber List as a CSV file